Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon Jan 09, 2020 8:23am
116 Views
Post# 30533664

RE:Absolutely Hopeless

RE:Absolutely HopelessRock, soon or later the share price will reflect its true value. The market and or share price can ramain distorted and irrational for a long long time but not for ever. Eventually one broker or two south of the border will notice and place a buy order. Boom. A full blown listing south of the border will also come and help but I suspect it will not be before GUD complete the takeover of GBT. GUD cannot and will not say much about GBT takeover untill all shares are fully bought. 
The nice great prospect of GUD is that it will not rely on one or to mega drugs for revenues that will eventualy expire. GUD will rely on a predictable basked of multi drugs  with many small wins. 
I say that the sshare price will start to dance by the end of this Year and into the long future. We have waited so long, now I smell and taste the wins. At last
Happy new Year and good luck to all us long shareholders
Bullboard Posts